Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02243709 · ClinicalTrials.gov registry record · Phase 1
Mifepristone for the Prevention of Relapses of Alcohol Drinking
A Phase 1 study, sponsored by Brown University.
- Completed
- Registry status
- Phase 1
- Development phase
- 32
- Enrollment target
NCT02243709 is a Phase 1 study that has completed, run by Brown University. The registered enrollment target is 32 participants.
The verdict
NCT02243709, a Phase 1 study, has completed, sponsored by Brown University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 32 participants
- Enrollment target
Study Summary
The goal of this study is to determine if, under stress, alcohol drinking is reduced using mifepristone
Interventions
- DRUG Mifepristone 600-mg/day or placebo for a week
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2014-09 |
| Est. Completion | 2021-12-21 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02243709
The ClinicalTrials.gov registry entry for NCT02243709 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brown University, which has 231 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mifepristone 600-mg/day or placebo for a week is the first listed.
NCT02243709 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02243709 about?
NCT02243709 is a clinical study titled "Mifepristone for the Prevention of Relapses of Alcohol Drinking". The goal of this study is to determine if, under stress, alcohol drinking is reduced using mifepristone
What is the current status of trial NCT02243709?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 32 participants. The study started on 2014-09. Estimated completion is 2021-12-21.
What interventions are being tested in trial NCT02243709?
The interventions under investigation include: Mifepristone 600-mg/day or placebo for a week (DRUG).
Who is sponsoring clinical trial NCT02243709?
This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.